Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
M. J. Tasman (B)
Horniman, Alexander B.; Brewster, MichaelCaso DARDEN-OB-0972-ELiderazgo y Dirección de personasM. J. Tasman was quite disappointed with the first year's engagement scores. He puts his new plan into action and the results don't change. In an attempt to deal with his problem, he gets some specific feedback as to what he might do differently.Desde 5,74 €
-
M. J. Tasman (A)
Horniman, Alexander B.; Brewster, MichaelCaso DARDEN-OB-0971-ELiderazgo y Dirección de personasM. J. Tasman had made the transition to his new organization, having been quite successful in a smaller one. After the first year he was shocked to see the "engagement scores" put forth by his people. He wondered how this could be and what he could do differently.Desde 8,20 €
-
M. J. Tasman (C)
Horniman, Alexander B.; Brewster, MichaelCaso DARDEN-OB-0973-ELiderazgo y Dirección de personasM. J. Tasman follows the feedback he was given, and changes his day-to-day behaviors. A year later, the results are quite improved. Although Tasman only changes some external behaviors, his internal structure seems to have been affected in a positive manner.Desde 5,74 €
-
Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester (Abridged)
Watkins, Michael D.; Knoop, Carin-Isabel; Reavis, CateCaso HBS-808074-EThis is a shortened version of The Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester, HBS case #9-800-355. It eliminates some background detail and the financial data and exhibits. As with the original case, it chronicles the appointment of Douglas Ivester as CEO of Coca-Cola and the missteps that led to his dismissal.Desde 8,20 €
-
M. J. Tasman (A), (B), and (C) - Teaching Note
Horniman, Alexander B.Nota del Instructor DARDEN-OB-0971TN-ELiderazgo y Dirección de personasTeaching note for product OB-0971Desde 0,00 €
-
Novartis Pharma: Modelo de la Unidad de Negocio
Datar, Srikant M.; Knoop, Carin-Isabel; Reavis, CateCaso HBS-110S30Contabilidad y controlEn junio de 2000, Novartis reorganizó su negocio farmacéutico para formar unidades de negocio globales en oncología, trasplante, oftalmología, y madurar productos. Los productos de cuidado primario restantes continuaron siendo administrado dentro de las funciones globales (por ejemplo, I + D y comercialización). La nueva organización creó una estructura de matriz y las nuevas funciones y responsabilidades de los jefes de las funciones de negocio,...Desde 8,20 €